Jelkmann (2011) stated that multiple mechanisms might contribute to anemia in renal diseases; tubular atrophy during chronic kidney disease generates tubule-interstitial fibrosis, leading to a reduction of erythropoietin synthetic capacity contributes to the associated anemia. The gene discussed is EPO; the disease is chronic kidney disease.